Novel motif:53
From FANTOM5_SSTAR
name: | motif53_ANGCTG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 5.416657e-15 |
GO:0031440 | regulation of mRNA 3'-end processing | 1.022647e-12 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.923953e-11 |
GO:0050685 | positive regulation of mRNA processing | 4.063278e-11 |
GO:0061014 | positive regulation of mRNA catabolic process | 2.032145e-10 |
GO:0061013 | regulation of mRNA catabolic process | 2.039313e-9 |
GO:0010625 | positive regulation of Schwann cell proliferation | 6.473005e-9 |
GO:0001885 | endothelial cell development | 1.297141e-8 |
GO:0000387 | spliceosomal snRNP assembly | 4.924375e-8 |
GO:0042424 | catecholamine catabolic process | 6.525988e-8 |
GO:0032012 | regulation of ARF protein signal transduction | 7.331988e-8 |
GO:0060837 | blood vessel endothelial cell differentiation | 1.006810e-7 |
GO:0045446 | endothelial cell differentiation | 1.615150e-7 |
GO:0060020 | Bergmann glial cell differentiation | 1.641525e-7 |
GO:0090130 | tissue migration | 2.393919e-7 |
GO:0045112 | integrin biosynthetic process | 3.390326e-7 |
GO:0051580 | regulation of neurotransmitter uptake | 3.544203e-7 |
GO:0008078 | mesodermal cell migration | 3.861048e-7 |
GO:0035814 | negative regulation of renal sodium excretion | 4.547045e-7 |
GO:0060014 | granulosa cell differentiation | 5.006327e-7 |
GO:0032855 | positive regulation of Rac GTPase activity | 5.064718e-7 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 5.370957e-7 |
GO:0042703 | menstruation | 1.094838e-6 |
GO:0019101 | female somatic sex determination | 1.094838e-6 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 1.158738e-6 |
GO:0034048 | negative regulation of protein phosphatase type 2A activity | 1.250801e-6 |
GO:0021526 | medial motor column neuron differentiation | 1.384900e-6 |
GO:0035572 | N-terminal peptidyl-serine dimethylation | 1.388004e-6 |
GO:0035573 | N-terminal peptidyl-serine trimethylation | 1.388004e-6 |
GO:0018016 | N-terminal peptidyl-proline dimethylation | 1.388004e-6 |
GO:0018012 | N-terminal peptidyl-alanine trimethylation | 1.388004e-6 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 1.955509e-6 |
GO:0019083 | viral transcription | 2.137911e-6 |
GO:0051546 | keratinocyte migration | 2.211165e-6 |
GO:0006415 | translational termination | 2.289279e-6 |
GO:0042069 | regulation of catecholamine metabolic process | 2.498402e-6 |
GO:0032007 | negative regulation of TOR signaling cascade | 2.686480e-6 |
GO:0032321 | positive regulation of Rho GTPase activity | 2.722188e-6 |
GO:0030237 | female sex determination | 3.547869e-6 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 4.171292e-6 |
GO:0002074 | extraocular skeletal muscle development | 4.289260e-6 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 4.928143e-6 |
GO:0070417 | cellular response to cold | 4.983520e-6 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 5.187296e-6 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 5.441959e-6 |
GO:0006691 | leukotriene metabolic process | 5.628027e-6 |
GO:0045606 | positive regulation of epidermal cell differentiation | 6.495008e-6 |
GO:0043241 | protein complex disassembly | 7.480679e-6 |
GO:0042420 | dopamine catabolic process | 8.306696e-6 |
GO:0042053 | regulation of dopamine metabolic process | 8.412563e-6 |
GO:0019058 | viral infectious cycle | 8.505014e-6 |
GO:0006772 | thiamine metabolic process | 8.711243e-6 |
GO:0045618 | positive regulation of keratinocyte differentiation | 8.711243e-6 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 8.801853e-6 |
GO:0046456 | icosanoid biosynthetic process | 9.501976e-6 |
GO:0015993 | molecular hydrogen transport | 9.847401e-6 |
GO:0042488 | positive regulation of odontogenesis of dentine-containing tooth | 1.101776e-5 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.216253e-5 |
GO:0003158 | endothelium development | 1.281011e-5 |
GO:0060611 | mammary gland fat development | 1.281754e-5 |
GO:0007509 | mesoderm migration involved in gastrulation | 1.419241e-5 |
GO:0043088 | regulation of Cdc42 GTPase activity | 1.456829e-5 |
GO:0071421 | manganese ion transmembrane transport | 1.481167e-5 |
GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin | 1.568127e-5 |
GO:0019370 | leukotriene biosynthetic process | 1.682916e-5 |
GO:0035307 | positive regulation of protein dephosphorylation | 1.727336e-5 |
GO:0046718 | entry of virus into host cell | 1.759787e-5 |
GO:0008156 | negative regulation of DNA replication | 1.979238e-5 |
GO:0070561 | vitamin D receptor signaling pathway | 1.981374e-5 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 2.049202e-5 |
GO:0051156 | glucose 6-phosphate metabolic process | 2.249469e-5 |
GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity | 2.312400e-5 |
GO:0015936 | coenzyme A metabolic process | 2.351249e-5 |
GO:0031282 | regulation of guanylate cyclase activity | 2.361380e-5 |
GO:0032695 | negative regulation of interleukin-12 production | 2.394156e-5 |
GO:0071603 | endothelial cell-cell adhesion | 2.699123e-5 |
GO:0002002 | regulation of angiotensin levels in blood | 2.708507e-5 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 2.730465e-5 |
GO:0035304 | regulation of protein dephosphorylation | 3.178078e-5 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 3.388999e-5 |
GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway | 3.400188e-5 |
GO:0030010 | establishment of cell polarity | 3.505393e-5 |
GO:0008366 | axon ensheathment | 3.520188e-5 |
GO:0006414 | translational elongation | 3.647108e-5 |
GO:0035306 | positive regulation of dephosphorylation | 4.077985e-5 |
GO:0015937 | coenzyme A biosynthetic process | 4.157638e-5 |
GO:0050779 | RNA destabilization | 4.260013e-5 |
GO:0002028 | regulation of sodium ion transport | 4.286144e-5 |
GO:0043624 | cellular protein complex disassembly | 4.337657e-5 |
GO:0042273 | ribosomal large subunit biogenesis | 4.750257e-5 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 4.750257e-5 |
GO:0043983 | histone H4-K12 acetylation | 4.838410e-5 |
GO:0006972 | hyperosmotic response | 4.863686e-5 |
GO:0051764 | actin crosslink formation | 4.878252e-5 |
GO:0048845 | venous blood vessel morphogenesis | 5.011356e-5 |
GO:0001826 | inner cell mass cell differentiation | 5.108145e-5 |
GO:0071391 | cellular response to estrogen stimulus | 5.207276e-5 |
GO:0002577 | regulation of antigen processing and presentation | 5.495106e-5 |
GO:0045345 | positive regulation of MHC class I biosynthetic process | 5.513433e-5 |
GO:0007398 | ectoderm development | 5.617660e-5 |
GO:0018993 | somatic sex determination | 5.844159e-5 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 5.926486e-5 |
GO:0032202 | telomere assembly | 5.938056e-5 |
GO:0070633 | transepithelial transport | 6.048777e-5 |
GO:0051135 | positive regulation of NK T cell activation | 6.273283e-5 |
GO:0043982 | histone H4-K8 acetylation | 6.653817e-5 |
GO:0043981 | histone H4-K5 acetylation | 6.653817e-5 |
GO:0051030 | snRNA transport | 6.745725e-5 |
GO:0045820 | negative regulation of glycolysis | 6.820732e-5 |
GO:0072593 | reactive oxygen species metabolic process | 6.998535e-5 |
GO:0001768 | establishment of T cell polarity | 7.500459e-5 |
GO:0060419 | heart growth | 7.564753e-5 |
GO:0007163 | establishment or maintenance of cell polarity | 8.365469e-5 |
GO:0050764 | regulation of phagocytosis | 8.997438e-5 |
GO:0033559 | unsaturated fatty acid metabolic process | 9.210415e-5 |
GO:0033700 | phospholipid efflux | 9.311234e-5 |
GO:0010624 | regulation of Schwann cell proliferation | 9.659761e-5 |
GO:0019062 | virion attachment to host cell surface receptor | 1.003757e-4 |
GO:0045059 | positive thymic T cell selection | 1.078624e-4 |
GO:0022415 | viral reproductive process | 1.079404e-4 |
GO:0014807 | regulation of somitogenesis | 1.081934e-4 |
GO:0034198 | cellular response to amino acid starvation | 1.180075e-4 |
GO:0034330 | cell junction organization | 1.323467e-4 |
GO:0032637 | interleukin-8 production | 1.380376e-4 |
GO:0046314 | phosphocreatine biosynthetic process | 1.424675e-4 |
GO:0048486 | parasympathetic nervous system development | 1.425720e-4 |
GO:0022411 | cellular component disassembly | 1.491898e-4 |
GO:0006690 | icosanoid metabolic process | 1.518222e-4 |
GO:0030853 | negative regulation of granulocyte differentiation | 1.539043e-4 |
GO:0055017 | cardiac muscle tissue growth | 1.544537e-4 |
GO:0050774 | negative regulation of dendrite morphogenesis | 1.595833e-4 |
GO:0045575 | basophil activation | 1.598033e-4 |
GO:0001694 | histamine biosynthetic process | 1.598033e-4 |
GO:0050862 | positive regulation of T cell receptor signaling pathway | 1.618337e-4 |
GO:0007296 | vitellogenesis | 1.698830e-4 |
GO:0003229 | ventricular cardiac muscle tissue development | 1.721175e-4 |
GO:0008610 | lipid biosynthetic process | 1.762157e-4 |
GO:0002367 | cytokine production involved in immune response | 1.790201e-4 |
GO:0001886 | endothelial cell morphogenesis | 1.805345e-4 |
GO:2000188 | regulation of cholesterol homeostasis | 2.027056e-4 |
GO:0000022 | mitotic spindle elongation | 2.027056e-4 |
GO:0010923 | negative regulation of phosphatase activity | 2.098389e-4 |
GO:0001692 | histamine metabolic process | 2.104028e-4 |
GO:0060706 | cell differentiation involved in embryonic placenta development | 2.132752e-4 |
GO:0065002 | intracellular protein transmembrane transport | 2.204616e-4 |
GO:0045908 | negative regulation of vasodilation | 2.249555e-4 |
GO:0018277 | protein deamination | 2.292138e-4 |
GO:0060177 | regulation of angiotensin metabolic process | 2.475145e-4 |
GO:0045061 | thymic T cell selection | 2.488843e-4 |
GO:0008643 | carbohydrate transport | 2.659493e-4 |
GO:0002579 | positive regulation of antigen processing and presentation | 2.697036e-4 |
GO:0032319 | regulation of Rho GTPase activity | 2.724867e-4 |
GO:0034616 | response to laminar fluid shear stress | 2.774869e-4 |
GO:0070574 | cadmium ion transmembrane transport | 2.909381e-4 |
GO:0045343 | regulation of MHC class I biosynthetic process | 3.007510e-4 |
GO:0002019 | regulation of renal output by angiotensin | 3.048504e-4 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 3.074470e-4 |
GO:0001771 | immunological synapse formation | 3.159877e-4 |
GO:0032312 | regulation of ARF GTPase activity | 3.359215e-4 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 3.359215e-4 |
GO:0042776 | mitochondrial ATP synthesis coupled proton transport | 3.399123e-4 |
GO:0003032 | detection of oxygen | 3.481487e-4 |
GO:0051973 | positive regulation of telomerase activity | 3.490582e-4 |
GO:0007028 | cytoplasm organization | 3.568326e-4 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 3.568326e-4 |
GO:0051937 | catecholamine transport | 3.575711e-4 |
GO:0030488 | tRNA methylation | 3.748510e-4 |
GO:0031508 | centromeric heterochromatin formation | 3.791950e-4 |
GO:0022601 | menstrual cycle phase | 3.817086e-4 |
GO:0051293 | establishment of spindle localization | 3.927918e-4 |
GO:0007195 | inhibition of adenylate cyclase activity by dopamine receptor signaling pathway | 3.957226e-4 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 4.039103e-4 |
GO:0071845 | cellular component disassembly at cellular level | 4.078474e-4 |
GO:0007051 | spindle organization | 4.123847e-4 |
GO:0007020 | microtubule nucleation | 4.192644e-4 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 4.426511e-4 |
GO:0050766 | positive regulation of phagocytosis | 4.568225e-4 |
GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep | 4.866994e-4 |
GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 5.071282e-4 |
GO:0015760 | glucose-6-phosphate transport | 5.071282e-4 |
GO:0032984 | macromolecular complex disassembly | 5.274639e-4 |
GO:0085020 | protein K6-linked ubiquitination | 5.302893e-4 |
GO:0033002 | muscle cell proliferation | 5.582210e-4 |
GO:0021846 | cell proliferation in forebrain | 5.818480e-4 |
GO:0048532 | anatomical structure arrangement | 5.934077e-4 |
GO:0006014 | D-ribose metabolic process | 6.286276e-4 |
GO:0044154 | histone H3-K14 acetylation | 6.314544e-4 |
GO:0090086 | negative regulation of protein deubiquitination | 6.491603e-4 |
GO:0007161 | calcium-independent cell-matrix adhesion | 6.601978e-4 |
GO:0046730 | induction of host immune response by virus | 6.820695e-4 |
GO:0042487 | regulation of odontogenesis of dentine-containing tooth | 6.820695e-4 |
GO:0044240 | multicellular organismal lipid catabolic process | 6.853516e-4 |
GO:0060038 | cardiac muscle cell proliferation | 7.142753e-4 |
GO:0045651 | positive regulation of macrophage differentiation | 7.176119e-4 |
GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | 7.319572e-4 |
GO:0006032 | chitin catabolic process | 7.320696e-4 |
GO:0044062 | regulation of excretion | 7.360065e-4 |
GO:0002540 | leukotriene production involved in inflammatory response | 7.503691e-4 |
GO:0090085 | regulation of protein deubiquitination | 7.660797e-4 |
GO:0035419 | activation of MAPK activity involved in innate immune response | 7.660797e-4 |
GO:0010763 | positive regulation of fibroblast migration | 7.741649e-4 |
GO:0061028 | establishment of endothelial barrier | 7.756605e-4 |
GO:0021984 | adenohypophysis development | 7.812472e-4 |
GO:0042552 | myelination | 7.832854e-4 |
GO:0045217 | cell-cell junction maintenance | 7.856768e-4 |
GO:0006909 | phagocytosis | 7.962941e-4 |
GO:0051323 | metaphase | 8.249577e-4 |
GO:0007000 | nucleolus organization | 8.254008e-4 |
GO:0018198 | peptidyl-cysteine modification | 8.649695e-4 |
GO:0050798 | activated T cell proliferation | 8.719759e-4 |
GO:0030336 | negative regulation of cell migration | 8.812085e-4 |
GO:0019228 | regulation of action potential in neuron | 8.861199e-4 |
GO:0006013 | mannose metabolic process | 8.999520e-4 |
GO:0033119 | negative regulation of RNA splicing | 9.143508e-4 |
GO:0007522 | visceral muscle development | 9.158792e-4 |
GO:0009226 | nucleotide-sugar biosynthetic process | 9.425222e-4 |
GO:0030382 | sperm mitochondrion organization | 9.473061e-4 |
GO:0030174 | regulation of DNA-dependent DNA replication initiation | 9.473061e-4 |
GO:0060251 | regulation of glial cell proliferation | 9.501420e-4 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 9.521173e-4 |
GO:0015684 | ferrous iron transport | 9.632585e-4 |
GO:0043534 | blood vessel endothelial cell migration | 9.671926e-4 |
GO:0071956 | cellular component maintenance at cellular level | 9.697441e-4 |
GO:0007143 | female meiosis | 9.746791e-4 |
GO:0045218 | zonula adherens maintenance | 9.776895e-4 |
GO:0006090 | pyruvate metabolic process | 9.797500e-4 |
GO:0071281 | cellular response to iron ion | 9.954951e-4 |
GO:0006026 | aminoglycan catabolic process | 1.006694e-3 |
GO:0010631 | epithelial cell migration | 1.007737e-3 |
GO:0001300 | chronological cell aging | 1.030020e-3 |
GO:0031627 | telomeric loop formation | 1.103452e-3 |
GO:0042407 | cristae formation | 1.103452e-3 |
GO:0031529 | ruffle organization | 1.114781e-3 |
GO:0003073 | regulation of systemic arterial blood pressure | 1.117706e-3 |
GO:0002523 | leukocyte migration involved in inflammatory response | 1.121038e-3 |
GO:0060124 | positive regulation of growth hormone secretion | 1.121314e-3 |
GO:0005993 | trehalose catabolic process | 1.123854e-3 |
GO:0015872 | dopamine transport | 1.132643e-3 |
GO:0060707 | trophoblast giant cell differentiation | 1.139113e-3 |
GO:0043537 | negative regulation of blood vessel endothelial cell migration | 1.166010e-3 |
GO:0015853 | adenine transport | 1.183957e-3 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 1.214416e-3 |
GO:0034776 | response to histamine | 1.226999e-3 |
GO:0015851 | nucleobase transport | 1.231802e-3 |
GO:0042396 | phosphagen biosynthetic process | 1.252724e-3 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 1.254037e-3 |
GO:0060178 | regulation of exocyst localization | 1.290244e-3 |
GO:0001928 | regulation of exocyst assembly | 1.290244e-3 |
GO:0006408 | snRNA export from nucleus | 1.290244e-3 |
GO:0060134 | prepulse inhibition | 1.303218e-3 |
GO:0032241 | positive regulation of nucleobase-containing compound transport | 1.306210e-3 |
GO:0060218 | hemopoietic stem cell differentiation | 1.318441e-3 |
GO:0031365 | N-terminal protein amino acid modification | 1.320507e-3 |
GO:0015747 | urate transport | 1.346054e-3 |
GO:0061077 | chaperone-mediated protein folding | 1.360258e-3 |
GO:0032862 | activation of Rho GTPase activity | 1.377644e-3 |
GO:0070904 | transepithelial L-ascorbic acid transport | 1.389693e-3 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 1.394276e-3 |
GO:0000226 | microtubule cytoskeleton organization | 1.400743e-3 |
GO:2000209 | regulation of anoikis | 1.402312e-3 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 1.410782e-3 |
GO:0048808 | male genitalia morphogenesis | 1.416979e-3 |
GO:0045604 | regulation of epidermal cell differentiation | 1.424345e-3 |
GO:0032964 | collagen biosynthetic process | 1.433262e-3 |
GO:0032717 | negative regulation of interleukin-8 production | 1.452109e-3 |
GO:0043001 | Golgi to plasma membrane protein transport | 1.459551e-3 |
GO:0051590 | positive regulation of neurotransmitter transport | 1.468661e-3 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 1.468661e-3 |
GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness | 1.471701e-3 |
GO:0021783 | preganglionic parasympathetic nervous system development | 1.472615e-3 |
GO:0034014 | response to triglyceride | 1.519569e-3 |
GO:0009133 | nucleoside diphosphate biosynthetic process | 1.519569e-3 |
GO:0021623 | oculomotor nerve formation | 1.577650e-3 |
GO:0003404 | optic vesicle morphogenesis | 1.577650e-3 |
GO:0003409 | optic cup structural organization | 1.577650e-3 |
GO:0046950 | cellular ketone body metabolic process | 1.577804e-3 |
GO:0007197 | inhibition of adenylate cyclase activity by muscarinic acetylcholine receptor signaling pathway | 1.594039e-3 |
GO:0002016 | regulation of blood volume by renin-angiotensin | 1.625972e-3 |
GO:0044236 | multicellular organismal metabolic process | 1.643460e-3 |
GO:0010765 | positive regulation of sodium ion transport | 1.669381e-3 |
GO:0019693 | ribose phosphate metabolic process | 1.673606e-3 |
GO:0045616 | regulation of keratinocyte differentiation | 1.678607e-3 |
GO:0030260 | entry into host cell | 1.722055e-3 |
GO:0045542 | positive regulation of cholesterol biosynthetic process | 1.743030e-3 |
GO:0051004 | regulation of lipoprotein lipase activity | 1.746147e-3 |
GO:0006264 | mitochondrial DNA replication | 1.750838e-3 |
GO:0034959 | endothelin maturation | 1.770487e-3 |
GO:0010816 | calcitonin catabolic process | 1.770487e-3 |
GO:0010814 | substance P catabolic process | 1.770487e-3 |
GO:0032720 | negative regulation of tumor necrosis factor production | 1.776710e-3 |
GO:0007213 | muscarinic acetylcholine receptor signaling pathway | 1.810581e-3 |
GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.822252e-3 |
GO:0032863 | activation of Rac GTPase activity | 1.822586e-3 |
GO:0072488 | ammonium transmembrane transport | 1.848090e-3 |
GO:0050704 | regulation of interleukin-1 secretion | 1.854734e-3 |
GO:0002005 | angiotensin catabolic process in blood | 1.857366e-3 |
GO:0034047 | regulation of protein phosphatase type 2A activity | 1.867051e-3 |
GO:0009992 | cellular water homeostasis | 1.867051e-3 |
GO:0003017 | lymph circulation | 1.867051e-3 |
GO:0034623 | cellular macromolecular complex disassembly | 1.894054e-3 |
GO:0050711 | negative regulation of interleukin-1 secretion | 1.923859e-3 |
GO:0046951 | ketone body biosynthetic process | 1.923859e-3 |
GO:0043314 | negative regulation of neutrophil degranulation | 1.937386e-3 |
GO:0042755 | eating behavior | 1.951495e-3 |
GO:0033865 | nucleoside bisphosphate metabolic process | 1.952841e-3 |
GO:0051918 | negative regulation of fibrinolysis | 1.967364e-3 |
GO:0043171 | peptide catabolic process | 1.975731e-3 |
GO:0032042 | mitochondrial DNA metabolic process | 1.986668e-3 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1.988542e-3 |
GO:0032204 | regulation of telomere maintenance | 2.026788e-3 |
GO:0043249 | erythrocyte maturation | 2.094093e-3 |
GO:0042147 | retrograde transport, endosome to Golgi | 2.100041e-3 |
GO:0030302 | deoxynucleotide transport | 2.112408e-3 |
GO:0032364 | oxygen homeostasis | 2.146981e-3 |
GO:0000244 | assembly of spliceosomal tri-snRNP | 2.195380e-3 |
GO:0035813 | regulation of renal sodium excretion | 2.195463e-3 |
GO:2000573 | positive regulation of DNA biosynthetic process | 2.207791e-3 |
GO:0030037 | actin filament reorganization involved in cell cycle | 2.222101e-3 |
GO:0001916 | positive regulation of T cell mediated cytotoxicity | 2.244833e-3 |
GO:0044058 | regulation of digestive system process | 2.265438e-3 |
GO:0090141 | positive regulation of mitochondrial fission | 2.307338e-3 |
GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep | 2.307628e-3 |
GO:0051152 | positive regulation of smooth muscle cell differentiation | 2.312009e-3 |
GO:0006682 | galactosylceramide biosynthetic process | 2.368608e-3 |
GO:0034766 | negative regulation of ion transmembrane transport | 2.368608e-3 |
GO:0048266 | behavioral response to pain | 2.391105e-3 |
GO:0060252 | positive regulation of glial cell proliferation | 2.394506e-3 |
GO:0010873 | positive regulation of cholesterol esterification | 2.394506e-3 |
GO:0000132 | establishment of mitotic spindle orientation | 2.408564e-3 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 2.410612e-3 |
GO:0060956 | endocardial cell differentiation | 2.425524e-3 |
GO:0010596 | negative regulation of endothelial cell migration | 2.456540e-3 |
GO:0034695 | response to prostaglandin E stimulus | 2.497498e-3 |
GO:0090162 | establishment of epithelial cell polarity | 2.522963e-3 |
GO:0051271 | negative regulation of cellular component movement | 2.602060e-3 |
GO:0030862 | positive regulation of polarized epithelial cell differentiation | 2.614483e-3 |
GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition | 2.614483e-3 |
GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation | 2.614483e-3 |
GO:0006021 | inositol biosynthetic process | 2.614483e-3 |
GO:0071955 | recycling endosome to Golgi transport | 2.627078e-3 |
GO:0034499 | late endosome to Golgi transport | 2.627078e-3 |
GO:0090136 | epithelial cell-cell adhesion | 2.630550e-3 |
GO:0015914 | phospholipid transport | 2.679467e-3 |
GO:0010984 | regulation of lipoprotein particle clearance | 2.689265e-3 |
GO:0000236 | mitotic prometaphase | 2.700612e-3 |
GO:0090205 | positive regulation of cholesterol metabolic process | 2.736861e-3 |
GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.814092e-3 |
GO:0045010 | actin nucleation | 2.825771e-3 |
GO:0033622 | integrin activation | 2.856009e-3 |
GO:0007321 | sperm displacement | 2.856009e-3 |
GO:0010735 | positive regulation of transcription via serum response element binding | 2.878316e-3 |
GO:0007144 | female meiosis I | 2.878316e-3 |
GO:0070307 | lens fiber cell development | 2.894548e-3 |
GO:0030953 | astral microtubule organization | 2.923029e-3 |
GO:0030321 | transepithelial chloride transport | 2.939717e-3 |
GO:0060267 | positive regulation of respiratory burst | 2.967978e-3 |
GO:0097150 | neuronal stem cell maintenance | 2.970771e-3 |
GO:0009817 | defense response to fungus, incompatible interaction | 3.066454e-3 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 3.066454e-3 |
GO:0090161 | Golgi ribbon formation | 3.066454e-3 |
GO:0048143 | astrocyte activation | 3.066454e-3 |
GO:0040001 | establishment of mitotic spindle localization | 3.066904e-3 |
GO:0008210 | estrogen metabolic process | 3.070185e-3 |
GO:0042048 | olfactory behavior | 3.100026e-3 |
GO:0021557 | oculomotor nerve development | 3.206082e-3 |
GO:0043462 | regulation of ATPase activity | 3.233718e-3 |
GO:0040015 | negative regulation of multicellular organism growth | 3.265240e-3 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 3.279846e-3 |
GO:0043547 | positive regulation of GTPase activity | 3.349406e-3 |
GO:0009119 | ribonucleoside metabolic process | 3.406808e-3 |
GO:0043932 | ossification involved in bone remodeling | 3.424785e-3 |
GO:0006911 | phagocytosis, engulfment | 3.433215e-3 |
GO:0006481 | C-terminal protein methylation | 3.486380e-3 |
GO:0034259 | negative regulation of Rho GTPase activity | 3.502409e-3 |
GO:0019344 | cysteine biosynthetic process | 3.502409e-3 |
GO:0043542 | endothelial cell migration | 3.513124e-3 |
GO:0051561 | elevation of mitochondrial calcium ion concentration | 3.521176e-3 |
GO:0022009 | central nervous system vasculogenesis | 3.549951e-3 |
GO:0019367 | fatty acid elongation, saturated fatty acid | 3.568857e-3 |
GO:0000920 | cytokinetic cell separation | 3.568857e-3 |
GO:0045404 | positive regulation of interleukin-4 biosynthetic process | 3.572124e-3 |
GO:0042136 | neurotransmitter biosynthetic process | 3.626629e-3 |
GO:2000974 | negative regulation of pro-B cell differentiation | 3.661212e-3 |
GO:0006826 | iron ion transport | 3.669313e-3 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 3.671302e-3 |
GO:0032376 | positive regulation of cholesterol transport | 3.675125e-3 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 3.781487e-3 |
GO:0035264 | multicellular organism growth | 3.823920e-3 |
GO:0051917 | regulation of fibrinolysis | 3.835764e-3 |
GO:0032914 | positive regulation of transforming growth factor beta1 production | 3.839674e-3 |
GO:0048194 | Golgi vesicle budding | 3.937374e-3 |
GO:0006140 | regulation of nucleotide metabolic process | 3.944840e-3 |
GO:0001990 | regulation of systemic arterial blood pressure by hormone | 3.949629e-3 |
GO:0010755 | regulation of plasminogen activation | 3.949629e-3 |
GO:0006656 | phosphatidylcholine biosynthetic process | 3.965667e-3 |
GO:0018026 | peptidyl-lysine monomethylation | 3.969927e-3 |
GO:0042508 | tyrosine phosphorylation of Stat1 protein | 3.987602e-3 |
GO:0044268 | multicellular organismal protein metabolic process | 4.005776e-3 |
GO:0006172 | ADP biosynthetic process | 4.005776e-3 |
GO:0032980 | keratinocyte activation | 4.055383e-3 |
GO:0010756 | positive regulation of plasminogen activation | 4.055383e-3 |
GO:0046833 | positive regulation of RNA export from nucleus | 4.088026e-3 |
GO:0090007 | regulation of mitotic anaphase | 4.088026e-3 |
GO:0008645 | hexose transport | 4.140820e-3 |
GO:0035305 | negative regulation of dephosphorylation | 4.159939e-3 |
GO:0032632 | interleukin-3 production | 4.174644e-3 |
GO:0045342 | MHC class II biosynthetic process | 4.174644e-3 |
GO:0070839 | divalent metal ion export | 4.174644e-3 |
GO:0043091 | L-arginine import | 4.174644e-3 |
GO:0006876 | cellular cadmium ion homeostasis | 4.174644e-3 |
GO:0015707 | nitrite transport | 4.174644e-3 |
GO:0032226 | positive regulation of synaptic transmission, dopaminergic | 4.174644e-3 |
GO:0060482 | lobar bronchus development | 4.232691e-3 |
GO:0006420 | arginyl-tRNA aminoacylation | 4.247154e-3 |
GO:2000077 | negative regulation of type B pancreatic cell development | 4.247154e-3 |
GO:0032098 | regulation of appetite | 4.280197e-3 |
GO:0046339 | diacylglycerol metabolic process | 4.332097e-3 |
GO:0033121 | regulation of purine nucleotide catabolic process | 4.346276e-3 |
GO:0010936 | negative regulation of macrophage cytokine production | 4.359872e-3 |
GO:0034260 | negative regulation of GTPase activity | 4.383517e-3 |
GO:0046513 | ceramide biosynthetic process | 4.418277e-3 |
GO:0031848 | protection from non-homologous end joining at telomere | 4.420493e-3 |
GO:0048144 | fibroblast proliferation | 4.420493e-3 |
GO:0000301 | retrograde transport, vesicle recycling within Golgi | 4.458387e-3 |
GO:0015844 | monoamine transport | 4.485553e-3 |
GO:0019321 | pentose metabolic process | 4.507823e-3 |
GO:0045402 | regulation of interleukin-4 biosynthetic process | 4.522550e-3 |
GO:0015749 | monosaccharide transport | 4.536773e-3 |
GO:0043313 | regulation of neutrophil degranulation | 4.560067e-3 |
GO:0051895 | negative regulation of focal adhesion assembly | 4.624713e-3 |
GO:0000089 | mitotic metaphase | 4.628458e-3 |
GO:0046101 | hypoxanthine biosynthetic process | 4.644380e-3 |
GO:0002513 | tolerance induction to self antigen | 4.644380e-3 |
GO:0034115 | negative regulation of heterotypic cell-cell adhesion | 4.651945e-3 |
GO:0010742 | macrophage derived foam cell differentiation | 4.651945e-3 |
GO:0001516 | prostaglandin biosynthetic process | 4.657991e-3 |
GO:0010875 | positive regulation of cholesterol efflux | 4.727783e-3 |
GO:0010954 | positive regulation of protein processing | 4.866685e-3 |
GO:0016032 | viral reproduction | 4.882626e-3 |
GO:0009298 | GDP-mannose biosynthetic process | 4.889737e-3 |
GO:0055072 | iron ion homeostasis | 4.896195e-3 |
GO:0045655 | regulation of monocyte differentiation | 4.916561e-3 |
GO:0001964 | startle response | 4.968679e-3 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 5.001409e-3 |
GO:0006386 | termination of RNA polymerase III transcription | 5.001409e-3 |
GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 5.004941e-3 |
GO:0010919 | regulation of inositol phosphate biosynthetic process | 5.051818e-3 |
GO:0010039 | response to iron ion | 5.058241e-3 |
GO:0044254 | multicellular organismal protein catabolic process | 5.070872e-3 |
GO:0002067 | glandular epithelial cell differentiation | 5.128437e-3 |
GO:0001836 | release of cytochrome c from mitochondria | 5.166336e-3 |
GO:0051788 | response to misfolded protein | 5.224124e-3 |
GO:0072060 | outer medullary collecting duct development | 5.268581e-3 |
GO:0072061 | inner medullary collecting duct development | 5.268581e-3 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 5.268581e-3 |
GO:0006600 | creatine metabolic process | 5.271759e-3 |
GO:0006200 | ATP catabolic process | 5.294488e-3 |
GO:0046687 | response to chromate | 5.328870e-3 |
GO:0033986 | response to methanol | 5.328870e-3 |
GO:0006879 | cellular iron ion homeostasis | 5.335451e-3 |
GO:0033962 | cytoplasmic mRNA processing body assembly | 5.378625e-3 |
GO:0042730 | fibrinolysis | 5.432575e-3 |
GO:0051584 | regulation of dopamine uptake | 5.432832e-3 |
GO:0006693 | prostaglandin metabolic process | 5.460622e-3 |
GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway | 5.518368e-3 |
GO:0031284 | positive regulation of guanylate cyclase activity | 5.520025e-3 |
GO:0060370 | susceptibility to T cell mediated cytotoxicity | 5.530037e-3 |
GO:0042503 | tyrosine phosphorylation of Stat3 protein | 5.540176e-3 |
GO:0048873 | homeostasis of number of cells within a tissue | 5.638914e-3 |
GO:0007260 | tyrosine phosphorylation of STAT protein | 5.700442e-3 |
GO:0021849 | neuroblast division in subventricular zone | 5.712480e-3 |
GO:0045955 | negative regulation of calcium ion-dependent exocytosis | 5.802339e-3 |
GO:0045039 | protein import into mitochondrial inner membrane | 5.812583e-3 |
GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep | 5.812583e-3 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 5.937652e-3 |
GO:0080009 | mRNA methylation | 5.940166e-3 |
GO:2000781 | positive regulation of double-strand break repair | 5.940166e-3 |
GO:0042747 | circadian sleep/wake cycle, REM sleep | 5.940166e-3 |
GO:0045212 | neurotransmitter receptor biosynthetic process | 5.940166e-3 |
GO:0032223 | negative regulation of synaptic transmission, cholinergic | 5.940166e-3 |
GO:0010523 | negative regulation of calcium ion transport into cytosol | 6.035985e-3 |
GO:0046731 | passive induction of host immune response by virus | 6.083848e-3 |
GO:0034314 | Arp2/3 complex-mediated actin nucleation | 6.083848e-3 |
GO:0051220 | cytoplasmic sequestering of protein | 6.194453e-3 |
GO:0072332 | signal transduction by p53 class mediator resulting in induction of apoptosis | 6.232398e-3 |
GO:0006667 | sphinganine metabolic process | 6.376188e-3 |
GO:0001766 | membrane raft polarization | 6.376188e-3 |
GO:0001845 | phagolysosome assembly | 6.376188e-3 |
GO:0007386 | compartment pattern specification | 6.381041e-3 |
GO:0003417 | growth plate cartilage development | 6.381041e-3 |
GO:2000146 | negative regulation of cell motility | 6.382148e-3 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 6.429508e-3 |
GO:0045109 | intermediate filament organization | 6.618388e-3 |
GO:0019883 | antigen processing and presentation of endogenous antigen | 6.623396e-3 |
GO:0003157 | endocardium development | 6.695859e-3 |
GO:0070613 | regulation of protein processing | 6.717914e-3 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 6.746984e-3 |
GO:0030579 | ubiquitin-dependent SMAD protein catabolic process | 6.761062e-3 |
GO:0070947 | neutrophil mediated killing of fungus | 6.828005e-3 |
GO:0060876 | semicircular canal formation | 6.828005e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0046031 | ADP metabolic process | 2.270343e-9 |
GO:0002444 | myeloid leukocyte mediated immunity | 3.219803e-8 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 1.263790e-7 |
GO:0043303 | mast cell degranulation | 2.286996e-7 |
GO:0045104 | intermediate filament cytoskeleton organization | 7.597972e-7 |
GO:0045055 | regulated secretory pathway | 1.162500e-6 |
GO:0045542 | positive regulation of cholesterol biosynthetic process | 1.276933e-6 |
GO:0045103 | intermediate filament-based process | 1.863743e-6 |
GO:0043299 | leukocyte degranulation | 1.873844e-6 |
GO:0046709 | IDP catabolic process | 1.935412e-6 |
GO:0046032 | ADP catabolic process | 1.935412e-6 |
GO:0032682 | negative regulation of chemokine production | 3.417704e-6 |
GO:0006360 | transcription from RNA polymerase I promoter | 3.570943e-6 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 4.334531e-6 |
GO:0032856 | activation of Ras GTPase activity | 4.461206e-6 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 5.469817e-6 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 6.992437e-6 |
GO:0006172 | ADP biosynthetic process | 7.026193e-6 |
GO:0043094 | cellular metabolic compound salvage | 7.236491e-6 |
GO:0070198 | protein localization to chromosome, telomeric region | 7.725117e-6 |
GO:0045453 | bone resorption | 9.256529e-6 |
GO:0031331 | positive regulation of cellular catabolic process | 1.018263e-5 |
GO:0006644 | phospholipid metabolic process | 1.057622e-5 |
GO:0090074 | negative regulation of protein homodimerization activity | 1.067151e-5 |
GO:0042554 | superoxide anion generation | 1.101737e-5 |
GO:0045796 | negative regulation of intestinal cholesterol absorption | 1.267519e-5 |
GO:0010949 | negative regulation of intestinal phytosterol absorption | 1.267519e-5 |
GO:0061077 | chaperone-mediated protein folding | 1.360390e-5 |
GO:0060457 | negative regulation of digestive system process | 1.396873e-5 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 1.452500e-5 |
GO:0006887 | exocytosis | 1.626248e-5 |
GO:0006629 | lipid metabolic process | 1.890486e-5 |
GO:0071702 | organic substance transport | 1.973441e-5 |
GO:0031329 | regulation of cellular catabolic process | 2.058706e-5 |
GO:0046501 | protoporphyrinogen IX metabolic process | 2.074428e-5 |
GO:0032206 | positive regulation of telomere maintenance | 2.074428e-5 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 2.304905e-5 |
GO:0044255 | cellular lipid metabolic process | 2.568318e-5 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 2.570052e-5 |
GO:0051127 | positive regulation of actin nucleation | 2.701525e-5 |
GO:0048002 | antigen processing and presentation of peptide antigen | 2.739376e-5 |
GO:0045576 | mast cell activation | 2.916093e-5 |
GO:0019882 | antigen processing and presentation | 2.965900e-5 |
GO:0009894 | regulation of catabolic process | 3.167812e-5 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 3.633175e-5 |
GO:0033504 | floor plate development | 4.087048e-5 |
GO:0032862 | activation of Rho GTPase activity | 4.273444e-5 |
GO:0048050 | post-embryonic eye morphogenesis | 4.429491e-5 |
GO:0035441 | cell migration involved in vasculogenesis | 4.942115e-5 |
GO:0035021 | negative regulation of Rac protein signal transduction | 4.942115e-5 |
GO:0015758 | glucose transport | 5.190843e-5 |
GO:0032863 | activation of Rac GTPase activity | 5.233570e-5 |
GO:0009132 | nucleoside diphosphate metabolic process | 5.440725e-5 |
GO:0042168 | heme metabolic process | 5.449109e-5 |
GO:0008645 | hexose transport | 5.648614e-5 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 5.651322e-5 |
GO:0051345 | positive regulation of hydrolase activity | 6.092997e-5 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 7.821588e-5 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 7.825664e-5 |
GO:0061014 | positive regulation of mRNA catabolic process | 7.989893e-5 |
GO:0042440 | pigment metabolic process | 8.480433e-5 |
GO:0090084 | negative regulation of inclusion body assembly | 8.617580e-5 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 8.789611e-5 |
GO:0070050 | neuron homeostasis | 9.245077e-5 |
GO:0046889 | positive regulation of lipid biosynthetic process | 9.283898e-5 |
GO:0015914 | phospholipid transport | 9.398402e-5 |
GO:0015749 | monosaccharide transport | 9.401960e-5 |
GO:0071715 | icosanoid transport | 9.671878e-5 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 9.959874e-5 |
GO:0050482 | arachidonic acid secretion | 1.024817e-4 |
GO:0009220 | pyrimidine ribonucleotide biosynthetic process | 1.198272e-4 |
GO:0000303 | response to superoxide | 1.230001e-4 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 1.266560e-4 |
GO:0007440 | foregut morphogenesis | 1.270707e-4 |
GO:0008643 | carbohydrate transport | 1.366720e-4 |
GO:0007340 | acrosome reaction | 1.399975e-4 |
GO:0060052 | neurofilament cytoskeleton organization | 1.417636e-4 |
GO:2000116 | regulation of cysteine-type endopeptidase activity | 1.473163e-4 |
GO:0090086 | negative regulation of protein deubiquitination | 1.485593e-4 |
GO:0009260 | ribonucleotide biosynthetic process | 1.487493e-4 |
GO:0043096 | purine base salvage | 1.524883e-4 |
GO:0002274 | myeloid leukocyte activation | 1.532854e-4 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 1.601504e-4 |
GO:0048102 | autophagic cell death | 1.601504e-4 |
GO:0032287 | peripheral nervous system myelin maintenance | 1.601504e-4 |
GO:0033137 | negative regulation of peptidyl-serine phosphorylation | 1.608177e-4 |
GO:0019637 | organophosphate metabolic process | 1.610754e-4 |
GO:0001824 | blastocyst development | 1.622867e-4 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 1.651046e-4 |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 1.676954e-4 |
GO:0043088 | regulation of Cdc42 GTPase activity | 1.687830e-4 |
GO:0031648 | protein destabilization | 1.742343e-4 |
GO:0031558 | induction of apoptosis in response to chemical stimulus | 1.771707e-4 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 1.829528e-4 |
GO:0032859 | activation of Ral GTPase activity | 1.965881e-4 |
GO:0060828 | regulation of canonical Wnt receptor signaling pathway | 2.073322e-4 |
GO:0071956 | cellular component maintenance at cellular level | 2.107891e-4 |
GO:0009896 | positive regulation of catabolic process | 2.239300e-4 |
GO:0006801 | superoxide metabolic process | 2.242199e-4 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 2.401004e-4 |
GO:0006997 | nucleus organization | 2.404339e-4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 2.444380e-4 |
GO:0046148 | pigment biosynthetic process | 2.554973e-4 |
GO:0070059 | apoptosis in response to endoplasmic reticulum stress | 2.577147e-4 |
GO:0060662 | salivary gland cavitation | 2.617254e-4 |
GO:0046483 | heterocycle metabolic process | 2.623120e-4 |
GO:0061013 | regulation of mRNA catabolic process | 2.627673e-4 |
GO:0060458 | right lung development | 2.680130e-4 |
GO:0048597 | post-embryonic camera-type eye morphogenesis | 2.680130e-4 |
GO:0022601 | menstrual cycle phase | 2.701222e-4 |
GO:0046903 | secretion | 2.717124e-4 |
GO:0033089 | positive regulation of T cell differentiation in thymus | 2.753298e-4 |
GO:0071034 | CUT catabolic process | 2.835297e-4 |
GO:0007352 | zygotic specification of dorsal/ventral axis | 2.896257e-4 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 2.896257e-4 |
GO:0070842 | aggresome assembly | 2.919599e-4 |
GO:0033505 | floor plate morphogenesis | 2.919599e-4 |
GO:0009119 | ribonucleoside metabolic process | 3.002291e-4 |
GO:0042538 | hyperosmotic salinity response | 3.094617e-4 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 3.125786e-4 |
GO:0045880 | positive regulation of smoothened signaling pathway | 3.136938e-4 |
GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development | 3.187591e-4 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 3.275906e-4 |
GO:0050701 | interleukin-1 secretion | 3.285386e-4 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 3.285386e-4 |
GO:0032940 | secretion by cell | 3.320172e-4 |
GO:0060014 | granulosa cell differentiation | 3.459270e-4 |
GO:0045620 | negative regulation of lymphocyte differentiation | 3.525925e-4 |
GO:0006003 | fructose 2,6-bisphosphate metabolic process | 3.544823e-4 |
GO:0042274 | ribosomal small subunit biogenesis | 3.677012e-4 |
GO:0048617 | embryonic foregut morphogenesis | 3.686912e-4 |
GO:0009218 | pyrimidine ribonucleotide metabolic process | 3.686912e-4 |
GO:0010660 | regulation of muscle cell apoptosis | 3.822097e-4 |
GO:0015884 | folic acid transport | 3.937830e-4 |
GO:0090083 | regulation of inclusion body assembly | 3.937830e-4 |
GO:0071529 | cementum mineralization | 4.066860e-4 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 4.093589e-4 |
GO:0009112 | nucleobase metabolic process | 4.366708e-4 |
GO:0070212 | protein poly-ADP-ribosylation | 4.486756e-4 |
GO:0032212 | positive regulation of telomere maintenance via telomerase | 4.486756e-4 |
GO:0032928 | regulation of superoxide anion generation | 4.532730e-4 |
GO:0006778 | porphyrin-containing compound metabolic process | 4.556648e-4 |
GO:0030111 | regulation of Wnt receptor signaling pathway | 4.581793e-4 |
GO:0046456 | icosanoid biosynthetic process | 4.588028e-4 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 4.621749e-4 |
GO:0071407 | cellular response to organic cyclic compound | 4.775058e-4 |
GO:0033007 | negative regulation of mast cell activation involved in immune response | 4.791860e-4 |
GO:0072593 | reactive oxygen species metabolic process | 4.825322e-4 |
GO:0002830 | positive regulation of type 2 immune response | 5.054136e-4 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 5.130938e-4 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB cascade | 5.158125e-4 |
GO:0006690 | icosanoid metabolic process | 5.185290e-4 |
GO:0006869 | lipid transport | 5.358713e-4 |
GO:0046112 | nucleobase biosynthetic process | 5.383972e-4 |
GO:0003273 | cell migration involved in endocardial cushion formation | 5.437607e-4 |
GO:0071392 | cellular response to estradiol stimulus | 5.443548e-4 |
GO:0043103 | hypoxanthine salvage | 5.516240e-4 |
GO:0032261 | purine nucleotide salvage | 5.516240e-4 |
GO:0019835 | cytolysis | 5.564940e-4 |
GO:0045089 | positive regulation of innate immune response | 5.596267e-4 |
GO:0019430 | removal of superoxide radicals | 5.679356e-4 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 5.766441e-4 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | 5.980299e-4 |
GO:0033013 | tetrapyrrole metabolic process | 6.118202e-4 |
GO:0032612 | interleukin-1 production | 6.366016e-4 |
GO:0007422 | peripheral nervous system development | 6.551656e-4 |
GO:0030177 | positive regulation of Wnt receptor signaling pathway | 6.559422e-4 |
GO:0032365 | intracellular lipid transport | 6.566710e-4 |
GO:0060711 | labyrinthine layer development | 6.605772e-4 |
GO:0033687 | osteoblast proliferation | 6.643082e-4 |
GO:0060696 | regulation of phospholipid catabolic process | 6.643082e-4 |
GO:0008333 | endosome to lysosome transport | 6.659395e-4 |
GO:0051299 | centrosome separation | 6.916038e-4 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 6.945769e-4 |
GO:0042574 | retinal metabolic process | 7.325930e-4 |
GO:0046655 | folic acid metabolic process | 7.866211e-4 |
GO:0006783 | heme biosynthetic process | 7.883854e-4 |
GO:0000305 | response to oxygen radical | 7.923403e-4 |
GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation | 8.084417e-4 |
GO:0070166 | enamel mineralization | 8.096193e-4 |
GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 8.330090e-4 |
GO:0071257 | cellular response to electrical stimulus | 8.442939e-4 |
GO:0071248 | cellular response to metal ion | 8.475720e-4 |
GO:0031081 | nuclear pore distribution | 8.876304e-4 |
GO:0006222 | UMP biosynthetic process | 8.957036e-4 |
GO:0045732 | positive regulation of protein catabolic process | 9.131102e-4 |
GO:0022411 | cellular component disassembly | 9.163343e-4 |
GO:0042993 | positive regulation of transcription factor import into nucleus | 9.169868e-4 |
GO:0071593 | lymphocyte aggregation | 9.213870e-4 |
GO:0010761 | fibroblast migration | 9.408310e-4 |
GO:0046849 | bone remodeling | 9.717232e-4 |
GO:0009133 | nucleoside diphosphate biosynthetic process | 9.825515e-4 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 9.825515e-4 |
GO:0018130 | heterocycle biosynthetic process | 9.935133e-4 |
GO:0070213 | protein auto-ADP-ribosylation | 1.003372e-3 |
GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation | 1.003372e-3 |
GO:0046210 | nitric oxide catabolic process | 1.014076e-3 |
GO:0090346 | cellular organofluorine metabolic process | 1.014076e-3 |
GO:0043602 | nitrate catabolic process | 1.014076e-3 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 1.014076e-3 |
GO:0001832 | blastocyst growth | 1.018529e-3 |
GO:0006144 | purine base metabolic process | 1.023671e-3 |
GO:0007274 | neuromuscular synaptic transmission | 1.033101e-3 |
GO:0015992 | proton transport | 1.056616e-3 |
GO:0002366 | leukocyte activation involved in immune response | 1.068353e-3 |
GO:0006818 | hydrogen transport | 1.068660e-3 |
GO:0015986 | ATP synthesis coupled proton transport | 1.080571e-3 |
GO:0060463 | lung lobe morphogenesis | 1.083890e-3 |
GO:0006702 | androgen biosynthetic process | 1.105127e-3 |
GO:0015876 | acetyl-CoA transport | 1.153150e-3 |
GO:0043173 | nucleotide salvage | 1.166377e-3 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 1.175374e-3 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 1.210088e-3 |
GO:0043616 | keratinocyte proliferation | 1.215986e-3 |
GO:0051297 | centrosome organization | 1.223737e-3 |
GO:0051546 | keratinocyte migration | 1.238486e-3 |
GO:0032463 | negative regulation of protein homooligomerization | 1.245702e-3 |
GO:0045217 | cell-cell junction maintenance | 1.245702e-3 |
GO:0015816 | glycine transport | 1.245702e-3 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 1.247317e-3 |
GO:0006650 | glycerophospholipid metabolic process | 1.250864e-3 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 1.280841e-3 |
GO:0050927 | positive regulation of positive chemotaxis | 1.289246e-3 |
GO:0016075 | rRNA catabolic process | 1.298519e-3 |
GO:0008654 | phospholipid biosynthetic process | 1.346350e-3 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.359120e-3 |
GO:0051125 | regulation of actin nucleation | 1.376444e-3 |
GO:0043101 | purine-containing compound salvage | 1.376444e-3 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 1.389816e-3 |
GO:0042891 | antibiotic transport | 1.389816e-3 |
GO:0042509 | regulation of tyrosine phosphorylation of STAT protein | 1.393156e-3 |
GO:0043392 | negative regulation of DNA binding | 1.422943e-3 |
GO:0002275 | myeloid cell activation involved in immune response | 1.436277e-3 |
GO:0042743 | hydrogen peroxide metabolic process | 1.509564e-3 |
GO:0048808 | male genitalia morphogenesis | 1.559515e-3 |
GO:0071845 | cellular component disassembly at cellular level | 1.571493e-3 |
GO:0009306 | protein secretion | 1.574531e-3 |
GO:0042662 | negative regulation of mesodermal cell fate specification | 1.587060e-3 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 1.591074e-3 |
GO:2000737 | negative regulation of stem cell differentiation | 1.616683e-3 |
GO:0002352 | B cell negative selection | 1.616683e-3 |
GO:0034391 | regulation of smooth muscle cell apoptosis | 1.694488e-3 |
GO:0033121 | regulation of purine nucleotide catabolic process | 1.695953e-3 |
GO:0051602 | response to electrical stimulus | 1.705908e-3 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 1.714653e-3 |
GO:0071285 | cellular response to lithium ion | 1.719187e-3 |
GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.719187e-3 |
GO:0051725 | protein de-ADP-ribosylation | 1.746914e-3 |
GO:0034661 | ncRNA catabolic process | 1.762809e-3 |
GO:0032864 | activation of Cdc42 GTPase activity | 1.771213e-3 |
GO:0045767 | regulation of anti-apoptosis | 1.782685e-3 |
GO:0035520 | monoubiquitinated protein deubiquitination | 1.810144e-3 |
GO:0009152 | purine ribonucleotide biosynthetic process | 1.813613e-3 |
GO:0016998 | cell wall macromolecule catabolic process | 1.820751e-3 |
GO:0031440 | regulation of mRNA 3'-end processing | 1.865371e-3 |
GO:0034505 | tooth mineralization | 1.870411e-3 |
GO:0044070 | regulation of anion transport | 1.890228e-3 |
GO:0048705 | skeletal system morphogenesis | 1.891536e-3 |
GO:0060716 | labyrinthine layer blood vessel development | 1.902187e-3 |
GO:0051668 | localization within membrane | 1.920879e-3 |
GO:0003032 | detection of oxygen | 1.928002e-3 |
GO:0052548 | regulation of endopeptidase activity | 1.932730e-3 |
GO:0033081 | regulation of T cell differentiation in thymus | 1.941659e-3 |
GO:0035966 | response to topologically incorrect protein | 2.038433e-3 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 2.066265e-3 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 2.169717e-3 |
GO:0035725 | sodium ion transmembrane transport | 2.218485e-3 |
GO:0018202 | peptidyl-histidine modification | 2.220598e-3 |
GO:0046427 | positive regulation of JAK-STAT cascade | 2.222785e-3 |
GO:0032849 | positive regulation of cellular pH reduction | 2.280928e-3 |
GO:0014044 | Schwann cell development | 2.283447e-3 |
GO:0072088 | nephron epithelium morphogenesis | 2.315543e-3 |
GO:0032321 | positive regulation of Rho GTPase activity | 2.324598e-3 |
GO:0038003 | opioid receptor signaling pathway | 2.363933e-3 |
GO:0031848 | protection from non-homologous end joining at telomere | 2.363933e-3 |
GO:0032479 | regulation of type I interferon production | 2.416952e-3 |
GO:0008209 | androgen metabolic process | 2.430015e-3 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 2.445018e-3 |
GO:0042703 | menstruation | 2.445456e-3 |
GO:0019101 | female somatic sex determination | 2.445456e-3 |
GO:0006258 | UDP-glucose catabolic process | 2.445456e-3 |
GO:0001579 | medium-chain fatty acid transport | 2.445456e-3 |
GO:0002443 | leukocyte mediated immunity | 2.445785e-3 |
GO:0010656 | negative regulation of muscle cell apoptosis | 2.466948e-3 |
GO:0009259 | ribonucleotide metabolic process | 2.514856e-3 |
GO:0051788 | response to misfolded protein | 2.541651e-3 |
GO:0006654 | phosphatidic acid biosynthetic process | 2.579058e-3 |
GO:0048859 | formation of anatomical boundary | 2.590698e-3 |
GO:0006657 | CDP-choline pathway | 2.592104e-3 |
GO:0070366 | regulation of hepatocyte differentiation | 2.597787e-3 |
GO:0060977 | coronary vasculature morphogenesis | 2.602454e-3 |
GO:0032984 | macromolecular complex disassembly | 2.616894e-3 |
GO:0002831 | regulation of response to biotic stimulus | 2.628782e-3 |
GO:0048148 | behavioral response to cocaine | 2.655925e-3 |
GO:0050926 | regulation of positive chemotaxis | 2.662890e-3 |
GO:0032319 | regulation of Rho GTPase activity | 2.735397e-3 |
GO:0001570 | vasculogenesis | 2.745171e-3 |
GO:0001833 | inner cell mass cell proliferation | 2.749791e-3 |
GO:0021508 | floor plate formation | 2.810364e-3 |
GO:0006168 | adenine salvage | 2.810364e-3 |
GO:0006000 | fructose metabolic process | 2.820130e-3 |
GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.837699e-3 |
GO:0071347 | cellular response to interleukin-1 | 2.858267e-3 |
GO:0006691 | leukotriene metabolic process | 2.902012e-3 |
GO:0001649 | osteoblast differentiation | 2.927291e-3 |
GO:0007184 | SMAD protein import into nucleus | 2.943753e-3 |
GO:0048566 | embryonic digestive tract development | 3.001173e-3 |
GO:0002858 | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.036626e-3 |
GO:0043503 | skeletal muscle fiber adaptation | 3.050459e-3 |
GO:0006927 | transformed cell apoptosis | 3.050459e-3 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 3.061283e-3 |
GO:0033344 | cholesterol efflux | 3.063182e-3 |
GO:0030162 | regulation of proteolysis | 3.087503e-3 |
GO:0015760 | glucose-6-phosphate transport | 3.175114e-3 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 3.210554e-3 |
GO:0002828 | regulation of type 2 immune response | 3.225611e-3 |
GO:0002358 | B cell homeostatic proliferation | 3.227106e-3 |
GO:0021526 | medial motor column neuron differentiation | 3.235928e-3 |
GO:0043280 | positive regulation of caspase activity | 3.293300e-3 |
GO:0051591 | response to cAMP | 3.300949e-3 |
GO:0032418 | lysosome localization | 3.302544e-3 |
GO:0070245 | positive regulation of thymocyte apoptosis | 3.304916e-3 |
GO:0046686 | response to cadmium ion | 3.338868e-3 |
GO:0046037 | GMP metabolic process | 3.347106e-3 |
GO:0010952 | positive regulation of peptidase activity | 3.374130e-3 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 3.417324e-3 |
GO:0035623 | renal glucose absorption | 3.417324e-3 |
GO:0001775 | cell activation | 3.438283e-3 |
GO:0001516 | prostaglandin biosynthetic process | 3.457334e-3 |
GO:0003308 | negative regulation of Wnt receptor signaling pathway involved in heart development | 3.462068e-3 |
GO:0061056 | sclerotome development | 3.462068e-3 |
GO:0070234 | positive regulation of T cell apoptosis | 3.507214e-3 |
GO:0060806 | negative regulation of cell differentiation involved in embryonic placenta development | 3.521359e-3 |
GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine | 3.521359e-3 |
GO:0006433 | prolyl-tRNA aminoacylation | 3.521359e-3 |
GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation | 3.530671e-3 |
GO:0044093 | positive regulation of molecular function | 3.654547e-3 |
GO:0032481 | positive regulation of type I interferon production | 3.657558e-3 |
GO:0070933 | histone H4 deacetylation | 3.697745e-3 |
GO:0048147 | negative regulation of fibroblast proliferation | 3.705409e-3 |
GO:0017156 | calcium ion-dependent exocytosis | 3.722208e-3 |
GO:0006817 | phosphate ion transport | 3.727008e-3 |
GO:0009110 | vitamin biosynthetic process | 3.758993e-3 |
GO:0060710 | chorio-allantoic fusion | 3.777682e-3 |
GO:0045332 | phospholipid translocation | 3.791774e-3 |
GO:0007243 | intracellular protein kinase cascade | 3.792818e-3 |
GO:0032872 | regulation of stress-activated MAPK cascade | 3.942020e-3 |
GO:0045578 | negative regulation of B cell differentiation | 3.948516e-3 |
GO:0022011 | myelination in peripheral nervous system | 3.964415e-3 |
GO:0021936 | regulation of cerebellar granule cell precursor proliferation | 3.964415e-3 |
GO:0006685 | sphingomyelin catabolic process | 3.980690e-3 |
GO:0061370 | testosterone biosynthetic process | 3.980690e-3 |
GO:0003140 | determination of left/right asymmetry in lateral mesoderm | 3.980690e-3 |
GO:0006998 | nuclear envelope organization | 4.017015e-3 |
GO:0006207 | 'de novo' pyrimidine base biosynthetic process | 4.056726e-3 |
GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 4.056920e-3 |
GO:0010833 | telomere maintenance via telomere lengthening | 4.074140e-3 |
GO:0051482 | elevation of cytosolic calcium ion concentration involved in G-protein signaling coupled to IP3 second messenger | 4.074751e-3 |
GO:0006693 | prostaglandin metabolic process | 4.087776e-3 |
GO:0007254 | JNK cascade | 4.117376e-3 |
GO:0002036 | regulation of L-glutamate transport | 4.187064e-3 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 4.228129e-3 |
GO:0071391 | cellular response to estrogen stimulus | 4.233682e-3 |
GO:0045862 | positive regulation of proteolysis | 4.258388e-3 |
GO:0010893 | positive regulation of steroid biosynthetic process | 4.313619e-3 |
GO:0014029 | neural crest formation | 4.327202e-3 |
GO:0046580 | negative regulation of Ras protein signal transduction | 4.332838e-3 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 4.393404e-3 |
GO:0051084 | 'de novo' posttranslational protein folding | 4.396982e-3 |
GO:0002227 | innate immune response in mucosa | 4.422717e-3 |
GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient | 4.441551e-3 |
GO:0006796 | phosphate-containing compound metabolic process | 4.470547e-3 |
GO:0006767 | water-soluble vitamin metabolic process | 4.507411e-3 |
GO:0043114 | regulation of vascular permeability | 4.559719e-3 |
GO:0034504 | protein localization to nucleus | 4.700389e-3 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 4.706640e-3 |
GO:0030513 | positive regulation of BMP signaling pathway | 4.713438e-3 |
GO:0061136 | regulation of proteasomal protein catabolic process | 4.715640e-3 |
GO:0042982 | amyloid precursor protein metabolic process | 4.771322e-3 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 4.776411e-3 |
GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation | 4.776411e-3 |
GO:0006904 | vesicle docking involved in exocytosis | 4.825375e-3 |
GO:0051984 | positive regulation of chromosome segregation | 4.835540e-3 |
GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport | 4.835540e-3 |
GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 4.835540e-3 |
GO:0090140 | regulation of mitochondrial fission | 4.835540e-3 |
GO:0006424 | glutamyl-tRNA aminoacylation | 4.835540e-3 |
GO:0010046 | response to mycotoxin | 4.835540e-3 |
GO:0002432 | granuloma formation | 4.835540e-3 |
GO:0007004 | telomere maintenance via telomerase | 4.835540e-3 |
GO:0043547 | positive regulation of GTPase activity | 4.862982e-3 |
GO:0061316 | canonical Wnt receptor signaling pathway involved in heart development | 4.895018e-3 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 4.896110e-3 |
GO:0009912 | auditory receptor cell fate commitment | 4.906768e-3 |
GO:0045581 | negative regulation of T cell differentiation | 4.915980e-3 |
GO:0070633 | transepithelial transport | 4.944697e-3 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 4.984352e-3 |
GO:0045768 | positive regulation of anti-apoptosis | 4.994409e-3 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 5.036450e-3 |
GO:0060406 | positive regulation of penile erection | 5.036450e-3 |
GO:0010288 | response to lead ion | 5.065588e-3 |
GO:0015802 | basic amino acid transport | 5.117573e-3 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 5.118623e-3 |
GO:0050665 | hydrogen peroxide biosynthetic process | 5.170827e-3 |
GO:0031272 | regulation of pseudopodium assembly | 5.170827e-3 |
GO:0006085 | acetyl-CoA biosynthetic process | 5.170827e-3 |
GO:0033622 | integrin activation | 5.185964e-3 |
GO:0071169 | establishment of protein localization to chromatin | 5.185964e-3 |
GO:0007506 | gonadal mesoderm development | 5.185964e-3 |
GO:0006409 | tRNA export from nucleus | 5.185964e-3 |
GO:0001546 | preantral ovarian follicle growth | 5.185964e-3 |
GO:0090085 | regulation of protein deubiquitination | 5.225248e-3 |
GO:0060769 | positive regulation of epithelial cell proliferation involved in prostate gland development | 5.225248e-3 |
GO:0006177 | GMP biosynthetic process | 5.225248e-3 |
GO:0018023 | peptidyl-lysine trimethylation | 5.286283e-3 |
GO:0006883 | cellular sodium ion homeostasis | 5.286283e-3 |
GO:0051298 | centrosome duplication | 5.289498e-3 |
GO:0043154 | negative regulation of caspase activity | 5.436970e-3 |
GO:0044241 | lipid digestion | 5.506751e-3 |
GO:0043217 | myelin maintenance | 5.550713e-3 |
GO:0007625 | grooming behavior | 5.550713e-3 |
GO:0060571 | morphogenesis of an epithelial fold | 5.576675e-3 |
GO:0035136 | forelimb morphogenesis | 5.701619e-3 |
GO:0019509 | L-methionine salvage from methylthioadenosine | 5.726005e-3 |
GO:0060370 | susceptibility to T cell mediated cytotoxicity | 5.726005e-3 |
GO:0009217 | purine deoxyribonucleoside triphosphate catabolic process | 5.726005e-3 |
GO:0000492 | box C/D snoRNP assembly | 5.726005e-3 |
GO:0010312 | detoxification of zinc ion | 5.726005e-3 |
GO:0048305 | immunoglobulin secretion | 5.746979e-3 |
GO:0046323 | glucose import | 5.755471e-3 |
GO:0060447 | bud outgrowth involved in lung branching | 5.755471e-3 |
GO:0010876 | lipid localization | 5.767680e-3 |
GO:0046425 | regulation of JAK-STAT cascade | 5.769341e-3 |
GO:0034623 | cellular macromolecular complex disassembly | 5.838345e-3 |
GO:0005981 | regulation of glycogen catabolic process | 5.884019e-3 |
GO:0043434 | response to peptide hormone stimulus | 5.886856e-3 |
GO:0006541 | glutamine metabolic process | 5.918797e-3 |
GO:0002446 | neutrophil mediated immunity | 5.967920e-3 |
GO:0071214 | cellular response to abiotic stimulus | 5.977390e-3 |
GO:0046824 | positive regulation of nucleocytoplasmic transport | 6.023017e-3 |
GO:0007032 | endosome organization | 6.076714e-3 |
GO:0032367 | intracellular cholesterol transport | 6.167811e-3 |
GO:0010939 | regulation of necrotic cell death | 6.168949e-3 |
GO:0006346 | methylation-dependent chromatin silencing | 6.177314e-3 |
GO:0001821 | histamine secretion | 6.317205e-3 |
GO:0006787 | porphyrin-containing compound catabolic process | 6.324557e-3 |
GO:0046131 | pyrimidine ribonucleoside metabolic process | 6.380471e-3 |
GO:0009165 | nucleotide biosynthetic process | 6.444239e-3 |
GO:0045109 | intermediate filament organization | 6.454327e-3 |
GO:0050823 | peptide antigen stabilization | 6.472976e-3 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 6.472976e-3 |
GO:0046373 | L-arabinose metabolic process | 6.472976e-3 |
GO:0018993 | somatic sex determination | 6.472976e-3 |
GO:0008616 | queuosine biosynthetic process | 6.472976e-3 |
GO:0006487 | protein N-linked glycosylation | 6.508703e-3 |
GO:0032874 | positive regulation of stress-activated MAPK cascade | 6.510325e-3 |
GO:0009150 | purine ribonucleotide metabolic process | 6.523433e-3 |
GO:0051261 | protein depolymerization | 6.533698e-3 |
GO:0032613 | interleukin-10 production | 6.630142e-3 |
GO:0052063 | induction by symbiont of defense-related host nitric oxide production | 6.637657e-3 |
GO:0050968 | detection of chemical stimulus involved in sensory perception of pain | 6.637657e-3 |
GO:0060461 | right lung morphogenesis | 6.637657e-3 |
GO:0090131 | mesenchyme migration | 6.637657e-3 |
GO:0048613 | embryonic ectodermal digestive tract morphogenesis | 6.637657e-3 |
GO:0060446 | branching involved in open tracheal system development | 6.637657e-3 |
GO:0006550 | isoleucine catabolic process | 6.637657e-3 |
GO:0048371 | lateral mesodermal cell differentiation | 6.637657e-3 |
GO:0009098 | leucine biosynthetic process | 6.637657e-3 |
GO:0014822 | detection of wounding | 6.637657e-3 |
GO:0042892 | chloramphenicol transport | 6.637657e-3 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 6.641152e-3 |
GO:0009129 | pyrimidine nucleoside monophosphate metabolic process | 6.676408e-3 |
GO:0009996 | negative regulation of cell fate specification | 6.702071e-3 |
GO:0003229 | ventricular cardiac muscle tissue development | 6.764015e-3 |
GO:0001556 | oocyte maturation | 6.787003e-3 |
GO:0009988 | cell-cell recognition | 6.805644e-3 |
GO:0010823 | negative regulation of mitochondrion organization | 6.822597e-3 |
GO:0045730 | respiratory burst | 6.831203e-3 |
GO:0009101 | glycoprotein biosynthetic process | 6.870343e-3 |
GO:0060688 | regulation of morphogenesis of a branching structure | 6.877356e-3 |
GO:0021542 | dentate gyrus development | 6.924349e-3 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 6.931475e-3 |
GO:0008630 | DNA damage response, signal transduction resulting in induction of apoptosis | 7.019181e-3 |
GO:0006518 | peptide metabolic process | 7.055941e-3 |
GO:0048278 | vesicle docking | 7.103726e-3 |
GO:0007029 | endoplasmic reticulum organization | 7.103726e-3 |
GO:0003009 | skeletal muscle contraction | 7.103726e-3 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 7.115839e-3 |
GO:0033004 | negative regulation of mast cell activation | 7.115839e-3 |
GO:0007218 | neuropeptide signaling pathway | 7.358818e-3 |
GO:0035813 | regulation of renal sodium excretion | 7.426202e-3 |
GO:0032048 | cardiolipin metabolic process | 7.469751e-3 |
GO:2000043 | regulation of cardiac cell fate specification | 7.469751e-3 |
GO:0046874 | quinolinate metabolic process | 7.471251e-3 |
GO:0046488 | phosphatidylinositol metabolic process | 7.660022e-3 |
GO:0006284 | base-excision repair | 7.710785e-3 |
GO:0050685 | positive regulation of mRNA processing | 7.952942e-3 |
GO:0031573 | intra-S DNA damage checkpoint | 7.999994e-3 |
GO:0007041 | lysosomal transport | 8.012369e-3 |
GO:0042074 | cell migration involved in gastrulation | 8.157666e-3 |